Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
H&R GmbH KGaA (LTS:0RRC) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
H&R GmbH KGaA Forward PE Ratio Related Terms
H&R GmbH KGaA Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for H&R GmbH KGaA's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H&R GmbH KGaA Forward PE Ratio Chart
H&R GmbH KGaA Annual Data
Trend
2024-12
2025-12
Forward PE Ratio
10.06
23.21
H&R GmbH KGaA Quarterly Data
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
Forward PE Ratio
10.06
12.18
20.04
22.73
23.21
26.26
LTS:0RRC vs LIN, SHW, ECL: Forward PE Ratio Comparison
For the Specialty Chemicals subindustry, H&R GmbH KGaA's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
H&R GmbH KGaA Forward PE Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, H&R GmbH KGaA's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where H&R GmbH KGaA's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
H&R GmbH KGaA (LTS:0RRC) has a Forward PE Ratio of 8.79 as of Jul. 29, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on H&R GmbH KGaA and its competitors. According to the industry distribution chart, H&R GmbH KGaA ranks #83 out of 660 companies in the Chemicals industry, placing it in the top 12.6%.
Is H&R GmbH KGaA's Forward PE Ratio too high?
H&R GmbH KGaA's current Forward PE Ratio is 8.79. The Chemicals industry median Forward PE Ratio is 17.47. H&R GmbH KGaA's value of 8.79 is 49.7% below this industry median. Based on the distribution chart, H&R GmbH KGaA ranks #83 out of 660 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, H&R GmbH KGaA has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does H&R GmbH KGaA's Forward PE Ratio compare to LIN and SHW?
According to the Chemicals industry distribution chart, H&R GmbH KGaA ranks #83 out of 660 companies for Forward PE Ratio. This places H&R GmbH KGaA in the top 13% of its industry — outperforming the majority of peers. The industry median Forward PE Ratio is 17.47. H&R GmbH KGaA's value of 8.79 is 49.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Chemicals company?
The median Forward PE Ratio among Chemicals companies is 17.47, based on 660 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. H&R GmbH KGaA's current Forward PE Ratio of 8.79 is 49.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on H&R GmbH KGaA and its competitors. For the Chemicals industry, the median Forward PE Ratio is 17.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. H&R GmbH KGaA's current Forward PE Ratio is 8.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H&R GmbH KGaA stock overvalued right now?
Based on GuruFocus' analysis, H&R GmbH KGaA (LTS:0RRC) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.09, compared to a current price of €6.10 — trading 49.1% above its estimated fair value. The current Forward PE Ratio is 8.79 and 49.7% below the Chemicals industry median of 17.47. H&R GmbH KGaA's overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For H&R GmbH KGaA (LTS:0RRC), the current Forward PE Ratio is 8.79 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H&R GmbH KGaA (LTS:0RRC) Overvalued in 2026?
Based on GuruFocus' analysis, H&R GmbH KGaA stock appears to be overvalued.
The current stock price of €6.10 is trading 49.1% above its estimated GF Value™ of €4.09.
GuruFocus considers H&R GmbH KGaA to be Significantly Overvalued.
Key valuation signals for LTS:0RRC:
Forward PE Ratio: 8.79
GF Value™: €4.09 vs. price of €6.10 (49.1% above fair value)
Industry Position: 49.7% below the Chemicals median (#83 of 660)
No single metric tells the full story. See the LTS:0RRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
H&R GmbH & Co KGaA is a manufacturer of chemical-pharmaceutical specialty products. The company organizes its operating activities into two business divisions: Chemical-Pharmaceutical Raw Materials and Plastics. It also has three business segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment produces specialty products from crude oil in the two domestic refineries (Hamburg-Neuhof and Salzbergen). Its ChemPharm Sales segment encompasses the production sites abroad as well as international sales activities. The company's Plastics segment manufactures high-precision plastic parts along with the associated tools and molds. The company derives a majority of its revenue from the ChemPharm Refining segment. Geographically, it derives key revenue from Germany.
68GF Score
Get the complete analysis for LTS:0RRC
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RRC has been successfully added to your 
